Assessment of Effects of the OPRD1 and OPRM1 Genes Encoding Opioid Receptors on Apathy in Schizophrenia


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Because of the involvement in motivational processes, opioid receptors are potential targets for apathy treatment in schizophrenia. We therefore searched for associations between the opioid receptor gene polymorphisms (OPRM1 (rs1799971) and OPRD1 (rs1042114, rs533123)) and apathy measured with the Apathy Evaluation Scale-S in a group of 284 schizophrenia patients. We analyzed individual genotypes, haplotypes, and the digenic interaction and observed nominally significant associations of rs1042114 genotypes and the rs1042114*rs1799971 interaction with behavioral apathy scores. The associations, however, did not withstand correction for multiple comparisons. Thus, the results did not provide enough evidence for the opioid receptor gene effects on apathy in schizophrenia patients.

作者简介

M. Alfimova

Mental Health Research Center

编辑信件的主要联系方式.
Email: m.alfimova@gmail.com
俄罗斯联邦, Moscow, 115522

G. Korovaitseva

Mental Health Research Center

Email: m.alfimova@gmail.com
俄罗斯联邦, Moscow, 115522

N. Kondratyev

Mental Health Research Center

Email: m.alfimova@gmail.com
俄罗斯联邦, Moscow, 115522

S. Smirnova

Mental Health Research Center

Email: m.alfimova@gmail.com
俄罗斯联邦, Moscow, 115522

T. Lezheiko

Mental Health Research Center

Email: m.alfimova@gmail.com
俄罗斯联邦, Moscow, 115522

V. Golimbet

Mental Health Research Center

Email: m.alfimova@gmail.com
俄罗斯联邦, Moscow, 115522

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2019